PROBiogen Inc
stock229.41
+3.70 (+1.64%)
Price as of 13 Oct, 12:20 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bullish
4 bull · 0 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD above signal line
%K below %D
Price near upper band — potential reversal
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+3.70
Market Cap
30411772000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Biogen Inc
What is Biogen Inc?
Biogen Inc. is a global biotechnology company focused on discovering and developing therapies for serious diseases, primarily in neurology and neuroscience. The company is well-known for its work on treatments for multiple sclerosis, spinal muscular atrophy, and more recently, Alzheimer's disease. They operate by researching complex biological processes and bringing innovative pharmaceutical products to the global market.
Is Biogen Inc a good investment?
Investors often look at Biogen for its strong R&D pipeline and potential for growth within the high-demand neurology sector, though the stock can be volatile due to clinical trial results and regulatory decisions. While the company has a history of market-leading treatments, it also faces challenges from generic competition and the inherent risks of biotech drug development. Please note that this information is for educational purposes and does not constitute financial advice.
How do you invest in Biogen Inc?
You can gain exposure to Biogen by purchasing its shares directly through a licensed brokerage account using the ticker symbol BIIB. Alternatively, you can invest indirectly by buying shares in healthcare-focused exchange-traded funds (ETFs) or mutual funds that include Biogen as part of their broader portfolio. Always ensure you have researched your chosen trading platform's fees and account requirements before placing an order.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for BIIB — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
Famous Investors Holding BIIB
Ken Griffin
418.4K sh · 0.0% of portfolio
$90.39M
NEW
Ken Fisher
338.0K sh · 0.0% of portfolio
$73.03M
NEW
Ken Griffin
315.0K sh · 0.0% of portfolio
$68.06M
NEW
Ken Griffin
134.2K sh · 0.0% of portfolio
$29.00M
NEW
Jim Simons
77.7K sh · 0.0% of portfolio
$16.80M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.